| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |